Evidence Hub

Evolving management strategies in head and neck paragangliomas: A single‐centre experience with 147 patients over a 60‐year period

J. Rijken, B. de Vos, L. V. van Hest, K. Dreijerink, M. den Heijer, W. Wisselink, G. Blom, E. Hensen et al.

Clinical Otolaryngology, 2019

147 participants · 22 citations

Abstract

•Paragangliomas of the head and neck (HNPGLs) are rare, slow-growing and usually benign tumours that arise in the paraganglion tissue associated with the autonomic nervous system. •Management strategies and outcome of 147 patients with a total of 289 HNPGLs in a 60-year period were evaluated. •In HNPGLs patients, the clinician should be aware of variable clinical manifestations, such as the risk of multifocality, associated sympathetic PGL, concurrent pheochromocytoma, catecholamine excess and risk of metastatic disease. •A decreasing number of HNPGLs were surgically resected. Increasingly, an active surveillance strategy has become the treatment of choice. •The genetic predisposition, a key factor in the clinical risk profile (phenotype) of HNPGL patient subgroups, in combination with a better understanding of the natural course of HNPGLs, has resulted in a more conservative management of HNPGL patients. This article is protected by copyright. All rights reserved.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free